Novo Nordisk said on Friday the U.S. Food and Drug Administration had granted accelerated approval for its weight-loss drug ...

Learn how to stop the progression of fatty liver disease with these common habit changes related to diet, exercise, and ...

Discover the critical insights from top liver specialist Dr. Saurabh Sethi on liver health, revealing facts about liver ...

MASLD has become the most common chronic liver disease worldwide. The authors review the features of the disease as well as ...

Fatty liver disease symptoms change as the disease progresses. You may not have symptoms early on, but upper-right abdominal ...

Novo Nordisk A/S’s weight-loss drug Wegovy has received FDA approval to treat a serious form of liver disease, giving the ...

China: A large-scale U.S. analysis has revealed that people living with both type 2 diabetes (T2DM) and chronic kidney ...

Ian "Big E" Berger has been a Miami Dolphins fans for 40 years, but he is fighting a life-threatening liver condition.

Grade 3 fatty liver disease is a severe form of fatty liver disease characterised by significant liver scarring. Early detection and treatment are important.

New European guidelines redefine Metabolic dysfunction-associated steatotic liver disease (MASLD) care, offering clearer ...

Novo Nordisk’s obesity drug Wegovy was cleared by U.S. regulators to treat an increasingly common liver disease, MASH.